159 related articles for article (PubMed ID: 22209710)
1. [Stereotactic body radiation therapy for liver primary and metastases: the Lille experience].
Dewas S; Mirabel X; Kramar A; Jarraya H; Lacornerie T; Dewas-Vautravers C; Fumagalli I; Lartigau É
Cancer Radiother; 2012 Feb; 16(1):58-69. PubMed ID: 22209710
[TBL] [Abstract][Full Text] [Related]
2. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.
Dewas S; Bibault JE; Mirabel X; Fumagalli I; Kramar A; Jarraya H; Lacornerie T; Dewas-Vautravers C; Lartigau E
Radiat Oncol; 2012 Oct; 7():166. PubMed ID: 23050794
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
6. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.
Ibarra RA; Rojas D; Snyder L; Yao M; Fabien J; Milano M; Katz A; Goodman K; Stephans K; El-Gazzaz G; Aucejo F; Miller C; Fung J; Lo S; Machtay M; Sanabria JR
Acta Oncol; 2012 May; 51(5):575-83. PubMed ID: 22263926
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
8. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
9. Robotic stereotactic body radiation therapy for tumors of the liver: radiation-induced liver disease, incidence and predictive factors.
Janoray G; Chapet S; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2014 Jun; 18(3):191-7. PubMed ID: 24837351
[TBL] [Abstract][Full Text] [Related]
10. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
[TBL] [Abstract][Full Text] [Related]
12. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
13. Complete resection of the caudate lobe of the liver with tumor: technique and experience.
Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Yu YQ
Hepatogastroenterology; 2001; 48(39):808-11. PubMed ID: 11462929
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
16. [The Cyberknife: experience of centre OSCAR-Lambret].
Lacornerie T; Mirabel X; Lartigau E
Cancer Radiother; 2009 Sep; 13(5):391-8. PubMed ID: 19640759
[TBL] [Abstract][Full Text] [Related]
17. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
19. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma.
Seo YS; Kim MS; Yoo SY; Cho CK; Choi CW; Kim JH; Han CJ; Park SC; Lee BH; Kim YH; Lee DH
J Surg Oncol; 2010 Sep; 102(3):209-14. PubMed ID: 20740576
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]